Acute caffeine differently affects risk-taking and the expression of BDNF and of adenosine and opioid receptors in rats with high or low anxiety-like behavior
Pharmacology Biochemistry and Behavior · 2023
DOI: 10.1016/j.pbb.2023.173573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2023. Verfasst von Sara Florén Lind und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Beijer Laboratory, Department of Pharmaceutical Biosciences, Neuropharmacology and Addiction Research, SE-751 24, Uppsala University, Uppsala, Sw…. Hauptthemen laut MEDLINE: Caffeine, Brain-Derived Neurotrophic Factor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Anxiety disorders are common psychiatric conditions with a partially elucidated neurobiology. Caffeine, an unspecific adenosine receptor antagonist, is a common psychostimulant with anxiogenic effects in sensitive individuals. High doses of caffeine produce anxiety-like behavior in rats but it is not known if this is specific for rats with high baseline anxiety-like behavior. Thus, the aim of this study was to investigate general behavior, risk-taking, and anxiety-like behavior, as well as mRNA expression (adenosine A2A and A1, dopamine D2, and, μ, κ, δ opioid, receptors, BDNF, c-fos, IGF-1) in amygdala, caudate putamen, frontal cortex, hippocampus, hypothalamus, after an acute dose of caffeine. Untreated rats were screened using the elevated plus maze (EPM), giving each rat a score on anxiety-like behavior based on their time spent in the open arms, and categorized into a high or low anxiety-like behavior group accordingly. Three weeks after categorization, the rats were treated with 50 mg/kg caffeine and their behavior profile was studied in the multivariate concentric square field (MCSF) test, and one week later in the EPM. qPCR was performed on selected genes and corticosterone plasma levels were measured using ELISA. The results demonstrated that the high anxiety-like behavior rats treated with caffeine spent less time in risk areas of the MCSF and resituated towards the sheltered areas, a behavior accompanied by lower mRNA expression of adenosine A2A receptors in caudate putamen and increased BDNF expression in hippocampus. These results support the hypothesis that caffeine affects individuals differently depending on their baseline anxiety-like behavior, possibly involving adenosine receptors. This highlights the importance of adenosine receptors as a possible drug target for anxiety disorders, although further research is needed to fully elucidate the neurobiological mechanisms of caffeine on anxiety disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Beijer Laboratory, Department of Pharmaceutical Biosciences, Neuropharmacology and Addiction Research, SE-751 24, Uppsala University, Uppsala, Sweden. Electronic address: sara.floren.lind@uu.se.
- The Beijer Laboratory, Department of Pharmaceutical Biosciences, Neuropharmacology and Addiction Research, SE-751 24, Uppsala University, Uppsala, Sweden. Electronic address: frida.stam@farmbio.uu.se.
- The Beijer Laboratory, Department of Pharmaceutical Biosciences, Neuropharmacology and Addiction Research, SE-751 24, Uppsala University, Uppsala, Sweden. Electronic address: sofia.zelleroth@farmbio.uu.se.
- The Beijer Laboratory, Department of Pharmaceutical Biosciences, Neuropharmacology and Addiction Research, SE-751 24, Uppsala University, Uppsala, Sweden.
- The Beijer Laboratory, Department of Medical Sciences, Psychiatry, SE-751 24, Uppsala University, Uppsala, Sweden. Electronic address: andreas.frick@neuro.uu.se.
- The Beijer Laboratory, Department of Pharmaceutical Biosciences, Neuropharmacology and Addiction Research, SE-751 24, Uppsala University, Uppsala, Sweden. Electronic address: alfhild.gronbladh@farmbio.uu.se.
Zitieren
APA
Florén Lind, S., Stam, F., Zelleroth, S., Meurling, E., Frick, A., & Grönbladh, A. (2023). Acute caffeine differently affects risk-taking and the expression of BDNF and of adenosine and opioid receptors in rats with high or low anxiety-like behavior. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2023.173573
Vancouver
Florén Lind S, Stam F, Zelleroth S, Meurling E, Frick A, Grönbladh A. Acute caffeine differently affects risk-taking and the expression of BDNF and of adenosine and opioid receptors in rats with high or low anxiety-like behavior. Pharmacology Biochemistry and Behavior. 2023. doi:10.1016/j.pbb.2023.173573
BibTeX
@article{FlornLind2023,
author = {Florén Lind, Sara and Stam, Frida and Zelleroth, Sofia and Meurling, Evelina and Frick, Andreas and Grönbladh, Alfhild},
title = {Acute caffeine differently affects risk-taking and the expression of BDNF and of adenosine and opioid receptors in rats with high or low anxiety-like behavior},
journal = {Pharmacology Biochemistry and Behavior},
year = {2023},
doi = {10.1016/j.pbb.2023.173573}
}
EUVIMED